Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Public information-services company whose Cortellis suite provides regulatory, drug-pipeline, and safety intelligence.
Clarivate, a public company headquartered in London (formed in 2016 from Thomson Reuters' IP & Science business), provides the Cortellis intelligence suite used across pharma R&D and regulatory functions — including regulatory intelligence for tracking global requirements and label changes, competitive pipeline intelligence, and AI-assisted safety literature triage. Its tools are data-and-intelligence products rather than transactional systems of record, and AI features vary by product line. In July 2026 Clarivate announced a definitive agreement to divest its Life Sciences & Healthcare segment (which includes Cortellis) to Altaris LLC for $600 million; the transaction is expected to close by the end of 2026 and had not completed as of late July 2026.
50% — Partial coverage. Coverage score — how completely Atlas documents Clarivate across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Regulatory Affairs, Pharmacovigilance, R&D Leadership
Adverse Event Detection, Natural Language Processing
Public, Founded 2016
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?